Form 4: Atara Biotherapeutics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Atara Biotherapeutics CEO Pascal Touchon sold shares of common stock on March 4, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On March 4, 2024, Pascal Touchon, the President and CEO of Atara Biotherapeutics, sold 24,844 shares of common stock.
- The shares were sold at a price of $0.72 per share.
- The sale was executed to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Touchon directly owns 1,910,652 shares of Atara Biotherapeutics.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of stock sale transaction |
| 03/06/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.